MedTrace Logo

Development of a Noninvasive Method of Evaluation of Pulmonary Inflammation in the Condensates of Exhaled Air

NCT00356629 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2008-11-14

No results posted yet for this study

Summary

The aim of the study is identify biological parameters reflecting proteolytic activity in the exhaled condenstaes which might be useful to follow up pulmonary inflammation in various conditions including cystic fibrosis, COPD, asthma, tobacco exposure. Three proteases will be analyzed, i.e. elastase, proteinase 3 and cathepsin G. Results in the condensates will be compared to those obtained in sputum.

Conditions

  • Bronchopulmonary Ignition
  • Condensate of Exhaled Air
  • Mucoviscidosis
  • Asthma

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • DIOT Patrice, Pr · service de Pneumologie et EFR CHRU Tours

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Completion
2008-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00356629 on ClinicalTrials.gov